Cargando…
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy
Metastatic castration-resistant prostate cancer is the lethal form of cancer of the prostate. Five new agents that prolong survival in this group have emerged in the past 5 years, and sipuleucel-T is among them. Sipuleucel-T is the only immunotherapy shown to improve survival in prostate cancer. It...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279604/ https://www.ncbi.nlm.nih.gov/pubmed/25565923 http://dx.doi.org/10.2147/CE.S54712 |